Baló's concentric sclerosislike lesion in the brainstem of a multiple sclerosis patient.
Kishimoto
Richiro
R
Yabe
Ichiro
I
Niino
Masaaki
M
Sato
Kazunori
K
Tsuji
Sachiko
S
Kikuchi
Seiji
S
Sasaki
Hidenao
H
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001259:Ataxia / Q000209:etiology / Q000503:physiopathology; D001933:Brain Stem / Q000473:pathology* / Q000503:physiopathology; D054022:Cerebrum / Q000473:pathology / Q000503:physiopathology; D003937:Diagnosis, Differential; D002549:Diffuse Cerebral Sclerosis of Schilder / Q000175:diagnosis*; D018450:Disease Progression; D004401:Dysarthria / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications / Q000175:diagnosis* / Q000503:physiopathology; D015835:Ocular Motility Disorders / Q000209:etiology / Q000503:physiopathology; D010291:Paresis / Q000209:etiology / Q000503:physiopathology; D013116:Spinal Cord / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D008775:Methylprednisolone